Search for: "Thomas v. Teva Pharmaceuticals USA, Inc. et al"
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
2 Jun 2011, 6:02 am
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
22 Jan 2015, 9:56 pm
USA, Inc. v. [read post]
18 Apr 2016, 9:58 am
USA, Inc. v. [read post]
7 Jun 2011, 10:12 am
Teva Pharmaceuticals USA, Inc., 10-1070 (second relist since the Court called for a response). [read post]
7 Jun 2011, 12:30 pm
Certiorari stage documents:Opinion below (2d Circuit)Petition for certiorariBrief in opposition of Steinbeck Heritage Foundation/Estate RespondentsPetitioners' replyAmicus brief of Graphic Artists Guild et al.Amicus brief of Penguin Group (USA), Inc. [read post]
24 Jun 2011, 3:25 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28,… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
